pefloxacin has been researched along with allopurinol in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Fiedor, P; Hardy, MA; Kwiatkowski, P; Oluwoie, SF; Puc, J; Rotbart-Fiedor, M; Rowinski, W | 1 |
Bobrow, M; Fiedor, P; Hardy, MA; Juszczak, M; Kwiatkowski, P; Mazurek, AP; Mrozek, A; Oluwole, SF; Puc, J; Rowinski, W | 1 |
6 other study(ies) available for pefloxacin and allopurinol
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of pefloxacin on rat pancreatic islet cell function after 24-hour cold preservation.
Topics: 4-Quinolones; Adenosine; Allopurinol; Animals; Anti-Infective Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Fluoroquinolones; Glucose; Glutathione; Insulin; Insulin Secretion; Islets of Langerhans; Microsomes; Organ Preservation Solutions; Oxidoreductases, N-Demethylating; Pefloxacin; Quinolones; Raffinose; Rats; Rats, Inbred Lew; Tissue Preservation | 1997 |
Evaluation of mitochondrial function after cold preservation of pancreatic islet cells from donors treated with pefloxacin.
Topics: 4-Quinolones; Adenosine; Allopurinol; Animals; Anti-Infective Agents; Cell Survival; Coculture Techniques; Cold Temperature; Fluoroquinolones; Glucose; Glutathione; Humans; Hypertonic Solutions; Insulin; Insulin Secretion; Interleukin-2; Islets of Langerhans; Lymphocytes; Mitochondria; Organ Preservation Solutions; Pefloxacin; Quinolones; Raffinose; Rats; Rats, Inbred WF; Tissue Preservation; Tumor Necrosis Factor-alpha | 1997 |